Article
Genetic variation in the serotonin transporter gene (5-HTTLPR, rs25531) influences the analgesic response to the short acting opioid Remifentanil in humans.
Molecular pain - 1 Jul 2009
Kosek Eva, Jensen Karin B, Lonsdorf Tina B, Schalling Martin, Ingvar Martin
Abstract excerpt
BACKGROUND: There is evidence from animal studies that serotonin (5-HT) can influence the antinociceptive effects of opioids at the spinal cord level. Therefore, there could be an influence of genetic polymorphisms in the serotonin system on individual variability in response to opioid treatment of pain. The serotonin transporter (5-HTT) is a key regulator of serotonin metabolism and availability and its gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
